Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FSE : 5NP) (the “Company” or “Havn Life”), is pleased to announce that it has entered into investor relations agreements with Media Relations Publishing (“MRP”) and Midam Ventures, LLC (“Midam”), respectively, pursuant to which, in exchange for payment by the Company of CAD$500,000 to each of MRP and Midam, respectively, they will provide marketing, advertising, public relations and corporate branding services to the Company.
On Behalf of The Board of Directors
Chief Executive Officer
About Havn Life Sciences Inc.
Havn Life Sciences is a Canadian biotechnology company pursuing standardized extraction of psychoactive compounds, the development of natural healthcare products, and innovative mental health treatment to support brain health and enhance the capabilities of the mind. Learn more at: havnlife.com and follow us on Facebook, Twitter and Instagram.
LinkedIn: @Havn Life